Publications

Peer-Reviewed Publications

Manuscripts

1.     Shirodkara A, Salamaa S, Pardhana A, Blackera S, Bolandb C, Butler MO, Cargilla DC, Chand AW, Cyr A, Faries MB, Forbes L, Hannah T, Hanrahan R, Hasegawa B, Higgins K , Joshua AM , Mitchell W, Moncrieff M, Morton R, Murray C, Nessim C , Petrella T, Pollett A, Sheffield B, Smith MJ and Wright FC. Defining Melanoma quality indicators: A Modified Delphi Approach Submitted to SSRN

2.     King A, Brandts-Longtin O, Somayaji C, McDonald JT, Li H, Aw K, Lau R, Lee A, Wong B, Grose E, Abed A, Stevenson J, Sheikh R, Johnson-Obaseki S, Nessim C. Impact of Social Determinants on Melanoma Outcomes in Canada: A Single-Centre Retrospective Study. J Surg Oncol. 2025 Aug 28. doi: 10.1002/jso.70069. Epub ahead of print. PMID: 40874540.

3.     van der Burg SJC, Fiore M, Rutkowski P, Albertsmeier M, Bonvalot S, Grignol VP, Raut CP, Cananzi FCM, Mullinax JE, Gyorki DE, Pennacchioli E, Ford SJ, Nessim C, Cardona K, Callegaro D, Skoczylas J, Lindner LH, Gronchi A, Van Houdt WJ; TransAtlantic Australasian Retroperitoneal Sarcoma Working Group. Radiologic and Pathologic Response Evaluation After Neoadjuvant Chemotherapy for Primary Retroperitoneal Sarcoma: A Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) Collaboration. Ann Surg Oncol. 2025 Jul;32(7):5359-5366. doi: 10.1245/s10434-025-17306-9. Epub 2025 May 15. PMID: 40374864.

4.     Maurichi A, Bartlett EK, Barretta F, Moy A, Podlipnik S, Puig S, Malvehy J, Wright FC, Walker R, Look- Hong N, Mocellin S, Tropea S, Dell'Olmo L, Borgognoni L, Sestini S, Gerlini G, Picciotto F, Quaglino P, Ribero S, Caracò C,Lucia B, Sparano F, Valerio DP, Florentia D, Peric B, Milicevic S, Roshan A, Durrani AJ, Egger ME, McMasters K, Manrique-Silva NE, Nessim C, Boada A, Manzano JL, Piñero A, Pablo, Karakousis G, Sharon C, Nizri E, Shimonovitz-Moore S, Calista D, Argenziano, Wagner NB, Zoras O, Lasithiotakis K, Ascierto P, Paradela S, Cañueto J, Rodríguez-Jiménez P, Gallo DJ, Solimani F, Mangas C, Espeli V, Bañuls P, Samaniego E, Muñoz Couselo E, de Unamuno B, Gori S, Tejera-Vaquerizo A, Miceli R, Marchetti MA, Santinami M. Development and Validation of a Nomogram for Individual Prediction of Disease-Recurrence or Melanoma-Specific Death in Patients with AJCC Stage IIIA Melanoma: an International, Retrospective, Multicenter Study, submitted to JCO

5.     Delisle M, Dingley B, Light A, Apte S, Mallick R, Hamilton T, Stuart H, Talbot M, McKinnon G, Jost E, Thiboutot E, Francescutti V, Samman S, Easson AM, Schellenberg A, Merchant S, La J, Vanderbeck K, Wright FC, Berger-Richardson D, Hebbard P, Hershorn O, Younan R, Patocskai E, Rodriguez-Qizilbash S, Meguerditchian A, Tchuente V, Kazandjian S, Mathieson A, Hossain F, Hetu J, Johnson-Obaseki S, Nessim C. Management and Outcomes of Merkel Cell Carcinoma in Canada Between 2000 and 2018 from the Pan-Canadian Merkel Cell Collaborative. Ann Surg Oncol. 2025 Aug;32(8):5387-5396. doi: 10.1245/s10434-025-17365-y. Epub 2025 May 3. PMID: 40319206.

6.     Winer LK, Fredette JD, Hasler J, Akumuo R, Greco SH, von Mehren M, Bartholomew AJ, Blazer DG, Gabrielova L, Adamkova D, Bernard-Bedard E, Nessim C, Kollár A, Olariu R, Cencelj-Arnez R, Hompes D, Ford SJ, Cardona K, Sato K, Iwata S, Farma JM, Villano AM. Examining the Impact of Biopsy Technique on Clinical and Pathologic Outcomes in Dermatofibrosarcoma Protuberans: An International, Multi-Institutional Study. Ann Surg Oncol. 2025 May;32(5):3752-3762. doi: 10.1245/s10434-025-17011-7. Epub 2025 Feb 27. PMID: 40014211.

7.     Snow H, Fiore M, Xie J, Strauss D, Tzanis D, Raut CP, Rutkowski P, Ford S, Swallow C, van Houdt WJ, Albertsmeier M, Cananzi F, Sicklick J, Cardona K, Grignol V, Nessim C, Nizri E, Novak M, Pennacchioli E, Valeri S, Callegaro D, Wilkinson M, Bonvalot S, Fairweather M, Skoczylas J, Tirotta F, Shapiro J, Angele MK, Gronchi A, Gyorki DE; Transatlantic Australasian Retroperitoneal Sarcoma Working Group. Global Variations in Patterns of Care for Retroperitoneal Sarcoma. Ann Surg. 2025 Jun 16. doi: 10.1097/SLA.0000000000006791. Epub ahead of print. PMID: 40519020.

8.     Mor E, Apte S, Mitchell C, Nessim C, Almond M, Vincenzi B, Lopez JAG, Cranmer L, Wagner MJ, Nissan A, Abreu MH, Albertsmeier M, Knoblauch M, Barlow A, Keung EZ, Grignani G, Hornick JL, Gronchi A, Gyorki DE. Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PEC): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG). Ann Surg Oncol. 2025 Jul 14. doi: 10.1245/s10434-025-17787-8. Epub ahead of print. Erratum in: Ann Surg Oncol. 2025 Jul 29. doi: 10.1245/s10434-025-18021-1. PMID: 40659896.

9.     Fairweather M, Jolissaint JS, Fiore M, Strauss D, Bonvalot S, Ford SJ, Nessim C., van Houdt WJ, Swallow C, Rutkowski P, Gronchi A, Raut CP; TransAtlantic Australasian Retroperitoneal Sarcoma Working Group. Development of a surgical complexity score to predict postoperative morbidity following primary retroperitoneal sarcoma resection: a collaborative study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG). Br J Surg. 2025 Mar 4;112(3): znaf029. doi: 10.1093/bjs/znaf029. PMID: 40111264.

10. Nessim C. (Collaborator – Ottawa Hospital Lead) COVID-Surg Collaborative. NIHR Global Health Research Unit on Global Surgery; STARSurg Collaborative. A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts. Lancet Digit Health. 2024 Jul;6(7):e507-e519. doi: 10.1016/S2589-7500(24)00065-7. PMID: 38906616; PMCID: PMC12056793.

11. Lee A, Wong B, Li H, Grose E, Brandts-Longtin O, Aw K, Lau R, Abed A, Stevenson J, Sheikh R, Chen R, Goulet C, Johnson-Obaseki S, Nessim C. Are Positive Biopsy Margins in Melanoma Significant? A Cohort Study of Micro- Versus Macroscopic Margin Status and Their Impact on Residual Disease and Survival. Ann Surg Oncol. 2025 Jan;32(1):474-481. doi: 10.1245/s10434-024-16301-w. Epub 2024 Oct 9. PMID: 39382747.

12. King A, Bai JQA, Nessim C. Postoperative Opioid Prescription Fill Rates and Consumption in Skin Cancer Patients: A Systematic Review. J Cutan Med Surg. 2025 May-Jun;29(3):299-300. doi: 10.1177/12034754241308236. Epub 2024 Dec 22. PMID: 39710620.

13. Winer LK, Akumuo R, Fredette JD, Deng M, Hasler JS, Greco SH, von Mehren M, Bartholomew AJ, Blazer DG, Gabrielova L, Adamkova D, Bernard-Bedard E, Nessim C, Kollár A, Olariu R, Cencelj-Arnez R, Hompes D, Ford SJ, Cardona K, Sato K, Iwata S, Farma JM, Villano AM. Current patterns of care and outcomes for dermatofibrosarcoma protuberans: An international multi-institutional collaborative. Cancer. 2025 Jan 1;131(1):e35468. doi: 10.1002/cncr.35468. Epub 2024 Jul 10. PMID: 38985726.

14. Fiore M, Sarre C, Callegaro D, Straus D, Fairweather M, Raut CP, Nessim C, Gronchi A on behalf of the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG). Primary pelvic soft tissue sarcomas (PELVISARC): outcomes from the TransAtlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG). Br J Surg. 2024 May 3;111(5): znae128. doi: 10.1093/bjs/znae128. PMID: 38805374; PMCID: PMC11132121.

15. Ivankovic V, Delisle M, Stacey D, Abou-Khalil J, Balaa F, Bertens KA, Dingley B, Martel G, McAlpine K, Nessim C, Tadros S, Carrier M, Auer RC. Testing of a risk-stratified patient decision aid to facilitate shared decision-making for extended postoperative thromboprophylaxis after major abdominal surgery for cancer. 2024 Can J Surgery 2024 Aug 27;67(4): E320-E328.doi: 10.1503/cjs.014722.

16. Wang J, Nessim C, Dingley B, Apte S, Auer R (2024) Don’t Touch the Bed! Capacitive Coupling in Electrosurgery Causes Current Loss During Pinch Burning. J Surg 9: 11060 DOI: 10.29011/2575-9760.11060.

17.  Rajagopal S, Yao X, Abadir W, Baetz TD, Easson A, Knight G, McWhirter E, Nessim C, Rosen CF, Sun A, Wright FC, Petrella TM. Surveillance evaluations in patients with stage I, II, III, or resectable IV melanoma who were treated with curative intent: A systematic review. Surg Oncol. 2024 Jun;54:102077. doi: 10.1016/j.suronc.2024.102077. Epub 2024 Apr 10. PMID: 38657486.

18.  Rajagopal S, Abadir W, Baetz TD, Easson A, Knight G, McWhirter E, Nessim C, Rosen CF, Sun A, Wright FC, Petrella TM. An Ontario Health (Cancer Care Ontario) clinical practice guideline: Surveillance strategies in patients with stage I, II, III, or resectable IV melanoma who were treated with curative intent. Clinical Oncology 2024;36(4):243-253.

19.  Alsadi N, Yahfoufi N, Nessim C, Matar C. Role of a Polyphenol-Enriched Blueberry Preparation on Inhibition of Melanoma Cancer Stem Cells and Modulation of MicroRNAs. Biomedicines. 2024 Jan 16;12(1):193. doi: 10.3390/biomedicines12010193. PMID: 38255297; PMCID: PMC10813708.

20.  Corn S, Nessim C, Roland CL, Gronchi A, Freeman C and Dumitra S. Data Dissemination of the Role of Neoadjuvant Radiation in Retroperitoneal Sarcoma: A CTOS and CSSO Survey. Current Oncology. 2023; 30: 5807-5815. doi: 10.3390/curroncol30060434.

21.  Allard-Coutu A, Dobson V, Schmitz E, Shah H, Nessim C. The Evolution of the Sentinel Node Biopsy in Melanoma. Life (Basel). 2023 Feb 10;13(2):489. doi: 10.3390/life13020489. PMID: 36836846; PMCID: PMC9966203.

22.  Nessim C. (Collaborator – Ottawa Hospital Lead) National Institute for Health and Care Research Global Health Research Unit on Global Surgery. Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries. Br J Surg. 2023 Jun 12;110(7):804-817. doi: 10.1093/bjs/znad092. Erratum in: Br J Surg. 2023 Nov 9;110(12):1907. doi: 10.1093/bjs/znad317. PMID: 37079880; PMCID: PMC10364528.

23.  Nayak AL, Pickett AT, Delisle M, Dingley B, Mallick R, Hamilton T, Stuart H, Talbot M, McKinnon G, Jost E, Thiboutot E, Francescutti V, Samman S, Easson A, Schellenberg A, Merchant S, La J, Vanderbeck K, Wright F, Berger-Richardson D, Hebbard P, Hershorn O, Younan R, Patocskai E, Rodriguez-Qizilbash S, Meguerditichian A, Tchuente V, Kazandjian S, Mathieson A, Hossain F, Hetu J, Corsten M, Tohmé A, Nessim C, Johnson-Obaseki S. Survival of Patients With Head and Neck Merkel Cell Cancer: Findings From the Pan-Canadian Merkel Cell Cancer Collaborative. JAMA Netw Open. 2023 Nov 1;6(11):e2344127. doi: 10.1001/jamanetworkopen.2023.44127. PMID: 37983027; PMCID: PMC10660167.

24. Whitaker J, Nessim C, Almond M, Ford SJ. Surveillance Post Surgery for Retroperitoneal Soft Tissue Sarcoma. Curr Oncol. 2023 Feb 26;30(3):2781-2791. doi: 10.3390/curroncol30030211.PMID36975424; PMCID: PMC10047263

25. Bergeron A, Nessim C, Kleiner O, Manion R, Dutz J, Philip A, Chan AW; Skin Investigation Network of Canada Priority Setting Collaborative. Skin Investigation Network of Canada (SkIN Canada) Priority Setting Initiative ranks the top 10 evidence uncertainties for Merkel cell carcinoma. Br J Dermatol. 2024 Jan 23;190(2):281-282. doi: 10.1093/bjd/ljad398. PMID: 37864824; PMCID: PMC10805522.

26.  Aw K, Lau R, Nessim C. Prioritizing Melanoma Surgeries to Prevent Wait Time Delays and Upstaging of Melanoma during the COVID-19 Pandemic. Curr Oncol. 2023 Sep 9;30(9):8328-8337. doi: 10.3390/curroncol30090604. PMID: 37754519; PMCID: PMC10528302.

27.  Mohsen ST, Price EL, Chan A-W, Hanna TP, Limacher JL, Nessim C, Shiers JE, Tron V, Wright FC, Drucker AM. Incidence, Mortality, and Survival of Merkel Cell Carcinoma: A Scoping Review of Population Based-Studies.Br J Dermatology. 2023 : ljad404. Doi: 10.1093/bjd/ljad404.

28.  Auer RC, Ott M, Karanicolas P, Brackstone MR, AShmalla S, Weaver J, Tagalakis V, Boutros M, Stotland P, Marulanda AC, Moloo H, Jayaraman S, Patel S, LeGal G, Spadafora S, MacLellan S, Torttier D, Jonker D, Asmis T, Mallick R, Pecarskie A, Ramsay T, Carrier M, Periop-01 Investigators (Nessim C.). Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trial. BMJ 2022 13:378:e071375. Doi:10.1136/bmj-2022-071375.

29.  Nessim C. (Collaborator – Ottawa Hospital Lead) NIHR Global Health Unit on Global Surgery; COVIDSurg Collaborative. Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries. Lancet. 2022 Nov 5;400(10363):1607-1617. doi: 10.1016/S0140-6736(22)01846-3. Epub 2022 Oct 31. PMID: 36328042; PMCID: PMC9621702.

30.  Nessim C. (Collaborator – Ottawa Hospital Lead) Fotopoulou C, Khan T, Bracinik J, Glasbey J, Abu-Rustum N, Chiva L, Fagotti A, Fujiwara K, Ghebre R, Gutelkin M, Konney TO, Ng J, Pareja R, Kottayasamy Seenivasagam R, Sehouli J, Surappa STS, Bhangu A, Leung E, Sundar S; CovidSurg Gynecological Cancer Collaborators. Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study. Am J Obstet Gynecol. 2022 Nov;227(5):735.e1-735.e25. doi: 10.1016/j.ajog.2022.06.052. Epub 2022 Jun 30. PMID: 35779589; PMCID: PMC9242690.

31. Nessim C. (Collaborator – Ottawa Hospital Lead) McKay SC; COVIDSurg Collaborative. Outcomes of patients undergoing elective liver and pancreas cancer surgery during the SARS-CoV-2 pandemic: an international, multicentre, prospective cohort study. HPB (Oxford). 2022 Oct;24(10):1668-1678. doi: 10.1016/j.hpb.2022.03.002. Epub 2022 Mar 16. PMID: 35562256; PMCID: PMC8925198.

32. Moncrieff MD, Lo SN, Scolyer RA, Heaton MJ, Nobes JP, Snelling AP, Carr MJ, Nessim C, Wade R, Peach AH, Kisyova R, Mason J, Wilson ED, Nolan G, Pritchard Jones R, Johansson I, Olofsson Bagge R, Wright LJ, Patel NG, Sondak VK, Thompson JF, Zager JS. Clinical Outcomes and Risk Stratification of Early-Stage Melanoma Micrometastases From an International Multicenter Study: Implications for the Management of American Joint Committee on Cancer IIIA Disease. J Clin Oncol. 2022 Dec 1;40(34):3940-3951. doi: 10.1200/JCO.21.02488. Epub 2022 Jul 18. PMID: 35849790.

33. Noh S, Nessim C, Keung EZ, Strauss D, Cananzi FCM, Chen J, Ford SJ, Rutkowski P, Pennacchioli E, Cardona K, Hompes D, Kollár A, Vassos N, Raut CP, Krakorova DA, Quildrian SD, Perhavec A, Nizri E, Farma JM, Vincenzi B, Lopez JAG, Iwata S, Kim T, Tolomeo F, Snow H, Tzanis D, Nikulin M, Gronchi A, and Sicklick JK. Retrospective analysis of Retroperitoneal-Abdominal-Pelvic Ganglioneuromas: An International Study by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group. Ann Surg. 2022; 278(2): 267-273. doi: 10.1097/SLA.0000000000005625.

34. Nessim C. (Collaborator – Ottawa Hospital Lead) COVIDSurg Collaborative. The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study. Colorectal Dis. 2022 Mar 14;24(6):708–26. doi: 10.1111/codi.16117. Epub ahead of print. PMID: 35286766; PMCID: PMC9322431.

35. Moncrieff MD, Lo SN, Scolyer RA, Heaton MJ, Nobes JP, Snelling AP, Carr MJ, Nessim C, Wade R, Peach AH, Kisyova R, Mason J, Wilson ED, Nolan G, Pritchard Jones R, Sondak VK, Thompson JF, Zager JS. Evaluation of the Indications for Sentinel Node Biopsy in Early-Stage Melanoma with the Advent of Adjuvant Systemic Therapy: An International, Multicenter Study. Ann Surg Oncol. 2022 Sep;29(9):5937-5945. doi: 10.1245/s10434-022-11761-4. Epub 2022 May 13. PMID: 35562521; PMCID: PMC9356930.

36. Tirotta F, Napolitano A, Noh S, Schmitz E, Nessim C, Patel D, Sicklick JK, Smith M, Thway K, van der Hage J, Ford SJ, Tseng WW. Current management of benign retroperitoneal tumors. Eur J Surg Oncol. 2023 Jun;49(6):1081-1090. doi: 10.1016/j.ejso.2022.07.006. Epub 2022 Jul 19. PMID: 35879135.

37. Parvez E, Khorsrow-Khavar F, Dumitra T, Bernard-Bedard E, Nessim C , Rivard J, Wang S, Pravong V, Gervais M-K, Meterissian S, Dumitra S.  Multi-center adoption and outcomes of nodal observation for patients with melanoma and sentinel lymph node metastases. Annals of Surg Onc. 2022; 30(2):1195-1205.  doi: 10.1245/s10434-022-12695-7.

38. Walker RJB, Look Hong NJ, Moncrieff M, van Akkooi ACJ, Jost E, Nessim C, van Houdt WJ, Stahlie EHA, Seo C, Quan ML, McKinnon JG, Wright FC, Mavros MN. Predictors of Sentinel Lymph Node Metastasis in Patients with Thin Melanoma: An International Multi-institutional Collaboration. Ann Surg Oncol. 2022 Oct;29(11):7010-7017. doi: 10.1245/s10434-022-11936-z. Epub 2022 Jun 8. PMID: 35676603.

39. Tseng WW, Swallow CJ, Strauss DC, Bonvalot S, Rutkowski P, Ford SJ, Gonzalez RJ, Gladdy RA, Gyorki DE, Fairweather M, Lee KW, Albertsmeier M, van Houdt WJ, Fau M, Nessim C, Grignani G, Cardona K, Quagliuolo V, Grignol V, Farma JM, Pennacchioli E, Fiore M, Hayes A, Tzanis D, Skoczylas J, Almond ML, Mullinax JE, Johnston W, Snow H, Haas RL, Callegaro D, Smith MJ, Bouhadiba T, Desai A, Voss R, Sanfilippo R, Jones RL, Baldini EH, Wagner AJ, Catton CN, Stacchiotti S, Thway K, Roland CL, Raut CP, Gronchi A; Transatlantic Australasian Retroperitoneal Sarcoma Working Group. Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group. Ann Surg Oncol. 2022 Nov;29(12):7335-7348. doi: 10.1245/s10434-022-11864-y. Epub 2022 Jun 29. PMID: 35767103.

40. Schmitz E, Nessim C. Retroperitoneal Sarcoma Care in 2021. Cancers (Basel). 2022 Mar 2;14(5):1293. doi: 10.3390/cancers14051293. PMID: 35267600; PMCID: PMC8909774.

41. Frenda G, Baker L, Zhang Y, Nessim C. Role of a skin bridge incision and prophylactic incisional negative-pressure wound therapy in the prevention of surgical site infection after inguinal lymph node dissection. Can J Surg. 2022 Oct 20;65(5): E688-E694. doi: 10.1503/cjs.005621. PMID: 36265898; PMCID: PMC9592091.

42. Nessim C. (Collaborator – Ottawa Hospital Lead) COVIDSurg Collaborative. COVID-19-related absence among surgeons: development of an international surgical workforce prediction model. BJS Open. 2021 Mar 5;5(2):zraa021. doi: 10.1093/bjsopen/zraa021. PMID: 33688956; PMCID: PMC7799259.

43. Nessim C. (Collaborator – Ottawa Hospital Lead) COVIDSurg Collaborative. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. Lancet Oncol. 2021 Nov;22(11):1507-1517. doi: 10.1016/S1470-2045(21)00493-9. Epub 2021 Oct 5. PMID: 34624250; PMCID: PMC8492020.

44. Nessim C. (Collaborator – Ottawa Hospital Lead) STARSurg Collaborative and COVIDSurg Collaborative. Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic. Br J Surg. 2021 Dec 1;108(12):1448-1464. doi: 10.1093/bjs/znab336. PMID: 34871379; PMCID: PMC10364875.

45. Küpper S, Austin JL, Dingley B, Xu Y, Kong K, Brar M, Wright FC, Nessim C, Bouchard-Fortier A, Quan ML. Extent of Groin Dissection in Melanoma: A Mixed-Methods, Population-Based Study of Practice Patterns and Outcomes. Curr Oncol. 2021 Dec 16;28(6):5422-5433. doi: 10.3390/curroncol28060452. PMID: 34940091; PMCID: PMC8700358.

46. Mussie A, Medor MC, Mohand-Said S, Ibrahim AM, Nessim C, Momtazi M. Eliminating the Burden of Lymphedema in Cancer Patients Requiring Nodal Dissections Using Prophylactic Immediate Lymphatic Reconstruction – A Case Report and Review of the Literature. Plastic Surgery Case Studies. 2021;7. doi:10.1177/2513826X211028930

47. Nessim C. (Collaborator – Ottawa Hospital Lead) COVIDSurg Collaborative; GlobalSurg Collaborative. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. Anaesthesia.2022 Jan;77(1):28-39. doi: 10.1111/anae.15563. Epub 2021 Aug 24. PMID: 34428858; PMCID: PMC8652887.

48. Nessim C. (Collaborator – Ottawa Hospital Lead) COVID-Surg Collaborative. COVIDSurg Collaborative. Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score. Br J Surg. 2021 Nov 11;108(11):1274-1292. doi: 10.1093/bjs/znab183. PMID: 34227657; PMCID: PMC8344569.

49. Gotfrit J, Goodwin R, Asmis T, Hyde AJ, Alcindor T, Aubin F, Berry S, Bossé D, Brown C, Burkes R, Burnell M, Colwell B, Corbett J, Craswell J, Daaboul N, Doherty M, Fleming DAB, Galvis L, Goel R, Harb M, Jeyakumar A, Jonker D, Kennedy E, Lock M, Mahmud A, McCrea PH, Nair V, Nassabein R, Nessim C, Ramjeesingh R, Raza M, Saliba W, Samimi S, Singh S, Snow S, Tehfé M, Thirlwell M, Valdes M, Welch S, Vickers M. Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019. Curr Oncol. 2021 May 26;28(3):1988-2006. doi: 10.3390/curroncol28030185. PMID: 34073199; PMCID: PMC8161825.

50. Boulva K, Apte S, Yu A, Tran A, Shorr R, Song X, Ong M, Nessim C. Contemporary Neoadjuvant Therapies for High-Risk Melanoma: A Systematic Review. Cancers (Basel). 2021 Apr 15;13(8):1905. doi: 10.3390/cancers13081905. PMID: 33920967; PMCID: PMC8071293.

51. Zhou S, Sikorski D, Xu H, Zubarev A, Chergui M, Lagacé F, Miller WH Jr, Redpath M, Ghazal S, Butler MO, Petrella TM, Claveau J, Nessim C, Salopek TG, Gniadecki R, Litvinov IV. Defining the Criteria for Reflex Testing for BRAF Mutations in Cutaneous Melanoma Patients. Cancers (Basel). 2021 May 10;13(9):2282. doi: 10.3390/cancers13092282. PMID: 34068774; PMCID: PMC8126223.

52. Apte SS, Radonjic A, Wong B, Dingley B, Boulva K, Chatterjee A, Purgina B, Ramsay T, Nessim C. Preoperative imaging of gastric GISTs underestimates pathologic tumor size: A retrospective, single institution analysis. J Surg Oncol. 2021 Jul;124(1):49-58. doi: 10.1002/jso.26494. Epub 2021 Apr 15. PMID: 33857332.

53. Nessim C, Raut CP, Callegaro D, Barretta F, Miceli R, Fairweather M, Blay JY, Strauss D, Rutkowski P, Ahuja N, Gonzalez R, Grignani G, Quagliuolo V, Stoeckle E, Lahat G, De Paoli A, Pillarisetty VG, Canter RJ, Mullen JT, Pennacchioli E, van Houdt W, Swallow CJ, Schrage Y, Cardona K, Fiore M, Gronchi A, Bagaria SP. Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG). Ann Surg Oncol. 2022 Mar 19. doi: 10.1245/s10434-022-11600-6. Epub ahead of print. Erratum for: Ann Surg Oncol. 2021 Nov;28(12):7854-7863. doi: 10.1245/s10434-021-10024-y. PMID: 35307808. (This article was used for the SSO: journal-based continuing medical education (CME)/Maintenance of Certification (MOC) program)

54. Nessim C. (Collaborator– Ottawa Hospital Lead) COVIDSurg Collaborative, GlobalSurg Collaborative. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study. Br J Surg. 2021 Sep 27;108(9):1056-1063. doi: 10.1093/bjs/znab101. PMID: 33761533; PMCID: PMC7995808.

55. Nessim C. (Collaborator– Ottawa Hospital Lead) COVIDSurg Collaborative; GlobalSurg Collaborative. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia. 2021 Jun;76(6):748-758. doi: 10.1111/anae.15458. Epub 2021 Mar 9. PMID: 33690889; PMCID: PMC8206995.

56. Bagaria SP, Swallow C, Suraweera H, Raut CP, Fairweather M, Cananzi F, Quagliuolo V, Grignani G, Hompes D, Ford SJ, Nessim C, Apte S, Skoczylas J, Rutkowski P, Bonvalot S, Tzanis D, Gabriel E, Pennacchioli E, Albertsmeier M, Canter RJ, Pollock R, Grignol V, Cardona K, Gamboa AC, Novak M, Stoeckle E, Almquist M, Ahuja N, Klemen N, Van Houdt W, Gyorki D, Gangi A, Rastrelli M, van der Hage J, Schrage Y, Valeri S, Conti L, Spiegel MR, Li Z, Fiore M, Gronchi A. Morbidity and Outcomes After Distal Pancreatectomy for Primary Retroperitoneal Sarcoma: An Analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group. Ann Surg Oncol. 2021 Oct;28(11):6882-6889. doi: 10.1245/s10434-021-09739-9. Epub 2021 Mar 19. Erratum in: Ann Surg Oncol. 2022 Mar 17. doi: 10.1245/s10434-022-11599-w. PMID: 33740198.

57. Milkovich J, Hanna T, Nessim C, Petrella TM, Weatherhead L, Chan AW, Irish JC, Murray C, Bannerman G, Holloway C, Forster K, Pazzano L, Wright FC, The Ontario Skin Cancer Advisory Committee. Restructuring Skin Cancer Care in Ontario: A Provincial Plan. Curr Oncol. 2021 Mar 12;28(2):1183-1196. doi: 10.3390/curroncol28020114. PMID: 33809399; PMCID: PMC8025818.

58. Keller BA, Laight BJ, Varette O, Broom A, Wedge MÈ, McSweeney B, Cemeus C, Petryk J, Lo B, Burns B, Nessim C, Ong M, Chica RA, Atkins HL, Diallo JS, Ilkow CS, Bell JC. Personalized oncology and BRAFK601N melanoma: model development, drug discovery, and clinical correlation. J Cancer Res Clin Oncol. 2021 May;147(5):1365-1378. doi: 10.1007/s00432-021-03545-2. Epub 2021 Feb 8. PMID: 33555379; PMCID: PMC11802029.

59. Swallow CJ, Strauss DC, Bonvalot S, Rutkowski P, Desai A, Gladdy RA, Gonzalez R, Gyorki DE, Fairweather M, van Houdt WJ, Stoeckle E, Park JB, Albertsmeier M, Nessim C, Cardona K, Fiore M, Hayes A, Tzanis D, Skoczylas J, Ford SJ, Ng D, Mullinax JE, Snow H, Haas RL, Callegaro D, Smith MJ, Bouhadiba T, Stacchiotti S, Jones RL, DeLaney T, Roland CL, Raut CP, Gronchi A; Transatlantic Australasian RPS Working Group (TARPSWG). Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group. Ann Surg Oncol. 2021 Nov;28(12):7873-7888. doi: 10.1245/s10434-021-09654-z. Epub 2021 Apr 14. PMID: 33852100; PMCID: PMC9257997.

60. Nessim C, Raut CP, Callegaro D, Barretta F, Miceli R, Fairweather M, Rutkowski P, Blay JY, Strauss D, Gonzalez R, Ahuja N, Grignani G, Quagliuolo V, Stoeckle E, De Paoli A, Pillarisetty VG, Swallow CJ, Bagaria SP, Canter RJ, Mullen JT, Schrage Y, Pennacchioli E, van Houdt W, Cardona K, Fiore M, Gronchi A, Lahat G. Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG). Ann Surg Oncol. 2021 May;28(5):2705-2714. doi: 10.1245/s10434-020-09445-y. Epub 2021 Jan 2. Erratum in: Ann Surg Oncol. 2022 Mar 19. doi: 10.1245/s10434-022-11602-4. PMID: 33389288.

61. Birdi HK, Jirovec A, Cortés-Kaplan S, Werier J, Nessim C, Diallo JS, Ardolino M. Immunotherapy for sarcomas: new frontiers and unveiled opportunities. J Immunother Cancer. 2021 Feb;9(2):e001580. doi: 10.1136/jitc-2020-001580. Erratum in: J Immunother Cancer. 2022 Apr;10(4):e001580corr1. doi: 10.1136/jitc-2020-001580corr1. PMID: 33526607; PMCID: PMC7852926.

62. Wong B, Apte SS, Tirotta F, Parente A, Mathieu J, Ford SJ, Desai A, Almond M, Nessim C. Perioperative blood transfusion is not an independent predictor for worse outcomes in retroperitoneal sarcoma surgery. Eur J Surg Oncol. 2021 Jul;47(7):1763-1770. doi: 10.1016/j.ejso.2021.01.007. Epub 2021 Jan 13. PMID: 33483237.

63. Tattersall HL, Hodson J, Cardona K, Lee RM, Nessim C, Gladdy R, Van Der Hage J, Schrage Y, Tseng WW, van Houdt W, Novak M, Grignani G, Tolomeo F, Goel N, Ryon E, Gyorki D, Bagaria SP, Gonzalez JA, Arnau ABM, Sayyed R, Tirotta F, Evenden C, Desai A, Almond M, Glasbey J, Fiore M, Gronchi A, Ford SJ. Primary mesenteric sarcomas: Collaborative experience from the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG). J Surg Oncol. 2021 Mar;123(4):1057-1066. doi: 10.1002/jso.26353. Epub 2020 Dec 23. Erratum in: J Surg Oncol. 2021 Sep;124(3):457. doi: 10.1002/jso.26582. PMID: 33368277.

64. Tseng WW, Barretta F, Conti L, Grignani G, Tolomeo F, Albertsmeier M, Angele MK, Rutkowski P, Skoczylas J, De Paoli A, Navarria F, Raut CP, Fairweather M, Farma JM, Nessim C, Goel N, Grignol VP, Ford SJ, Cardona K, Subhawong T, Tattersall HL, Lee RM, Hu JS, von Mehren M, Sanfilippo R, Gronchi A. Defining the role of neoadjuvant systemic therapy in high-risk retroperitoneal sarcoma: A multi-institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group. Cancer. 2021 Mar 1;127(5):729-738. doi: 10.1002/cncr.33323. Epub 2020 Nov 18. PMID: 33206381.

65. Nessim C. (Collaborator– Ottawa Hospital Lead) COVIDSurg Collaborative; GlobalSurg Collaborative. Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study. Anaesthesia. 2021 Nov;76(11):1454-1464. doi: 10.1111/anae.15560. Epub 2021 Aug 9. PMID: 34371522.

66. Nessim C. (Collaborator – Ottawa Hospital Lead) COVIDSurg Collaborative. Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic. Br J Surg. 2021 Jan 27;108(1):88-96. doi: 10.1093/bjs/znaa051. PMID: 33640908; PMCID: PMC7717156.

67. Nessim C. (Collaborator– Ottawa Hospital Lead) COVID-Surg-Cancer Collaborative. Glasbey JC, Nepogodiev D, Simoes JFF, Omar O, Li E, Venn ML, Pgdme, Abou Chaar MK, Capizzi V, Chaudhry D, Desai A, Edwards JG, Evans JP, Fiore M, Videria JF, Ford SJ, Ganly I, Griffiths EA, Gujjuri RR, Kolias AG, Kaafarani HMA, Minaya-Bravo A, McKay SC, Mohan HM, Roberts KJ, San Miguel-Méndez C, Pockney P, Shaw R, Smart NJ, Stewart GD, Sundar Mrcog S, Vidya R, Bhangu AA; COVIDSurg Collaborative. Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study. J Clin Oncol. 2021 Jan 1;39(1):66-78. doi: 10.1200/JCO.20.01933. Epub 2020 Oct 6. PMID: 33021869; PMCID: PMC8189635.

68. Li HO, Bailey AJ, Grose E, McDonald JT, Quimby A, Johnson-Obaseki S, Nessim C. Socioeconomic Status and Melanoma in Canada: A Systematic Review. J Cutan Med Surg. 2021 Jan-Feb;25(1):87-94. doi: 10.1177/1203475420960426. Epub 2020 Sep 21. PMID: 32955341.

69. Nessim C. (Collaborator– Ottawa Hospital Lead) COVIDSurg Collaborative. Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic. Colorectal Dis. 2020 Nov 15;23(3):732–49. doi: 10.1111/codi.15431. Epub ahead of print. PMID: 33191669; PMCID: PMC7753519.

70. Nessim C. (Collaborator– Ottawa Hospital Lead) COVIDSurg Collaborative. Delaying surgery for patients with a previous SARS-CoV-2 infection. Br J Surg. 2020 Nov;107(12):e601-e602. doi: 10.1002/bjs.12050. Epub 2020 Sep 25. PMID: 32974904; PMCID: PMC7537063.

71. van Houdt WJ, Fiore M, Barretta F, Rutkowski P, Blay JY, Lahat G, Strauss D, Gonzalez RJ, Ahuja N, Grignani G, Quagliuolo V, Stoeckle E, De Paoli A, Schrage Y, Cardona K, Pennacchioli E, Pillarisetty VG, Nessim C, Swallow CJ, Bagaria SP, Canter R, Mullen JT, Callegaro D, Fairweather M, Miceli R, Raut CP, Gronchi A, Gladdy RA. Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG. Cancer. 2020 Nov 15;126(22):4917-4925. doi: 10.1002/cncr.33139. Epub 2020 Aug 14. PMID: 32797703.

72. Wright FC, Kellett S, Hong NJL, Sun AY, Hanna TP, Nessim C, Giacomantonio CA, Temple-Oberle CF, Song X, Petrella TM. Locoregional management of in-transit metastasis in melanoma: an Ontario Health (Cancer Care Ontario) clinical practice guideline. Curr Oncol. 2020 Jun;27(3):e318-e325. doi: 10.3747/co.27.6523. Epub 2020 Jun 1. PMID: 32669939; PMCID: PMC7339852.

73. Ibrahim AM, Le May M, Bossé D, Marginean H, Song X, Nessim C, Ong M. Correction to: Imaging Intensity and Survival Outcomes in High-Risk Resected Melanoma Treated by Systemic Therapy at Recurrence. Ann Surg Oncol. 2020 Dec;27(Suppl 3):976-977. doi: 10.1245/s10434-020-08618-z. Erratum for: Ann Surg Oncol. 2020 Oct;27(10):3683-3691. doi: 10.1245/s10434-020-08407-8. PMID: 32444913. (An editorial was written about this article by authors from Memorial Sloan Kettering Cancer Center in NY,  in Annals of Surgical Oncology https://link.springer.com/article/10.1245/s10434-020-08633-0)

74. Monteiro-de-Barros J, Hodson J, Glasbey J, Massey R, Rintoul-Hoad O, Chetan M, Desai A, Almond M, Gourevitch D, Strauss D, Smith H, Cardona K, Lopez-Aguiar A, Johnson A, Swallow C, Burtenshaw S, Nessim C, Weng R, Purgina B, Gronchi A, Fiore M, Vallegro D, Raut C, Fairweather M, Bagaria S, Novak M, Gyorki D, Reid F, Mullinax J, Gonzalez R, van Coeverden F, van Houdt W, Haas R, van Boven H, Heeres B, Ford S.  Intercontinental collaborative experience with abdominal, retroperitoneal and pelvic schwannomas. Br J Surg. 2020 Mar;107(4):452-463. doi: 10.1002/bjs.11376. Epub 2019 Nov 17. PMID: 31736066.

75. Wright FC, Souter LH, Kellett S, Easson A, Murray C, Toye J, McCready D, Nessim C, Ghazarian D, Hong NJL, Johnson S, Goldstein DP, Petrella T; Melanoma Disease Site Group. Primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in cutaneous melanoma: a clinical practice guideline. Curr Oncol. 2019 Aug;26(4): e541-e550. doi: 10.3747/co.26.4885. Epub 2019 Aug 1. PMID: 31548823; PMCID: PMC6726255.

76. Pang G, Look Hong NJ, Paull G, Dobransky J, Kupper S, Hurton S, Kagedan DJ, Quan ML, Helyer L, Nessim C, Wright FC. Squamous Cell Carcinoma with Regional Metastasis to Axilla or Groin Lymph Nodes: a Multicenter Outcome Analysis. Ann Surg Oncol. 2019 Dec;26(13):4642-4650. doi: 10.1245/s10434-019-07743-8. Epub 2019 Aug 22. PMID: 31440926.

77. Berger-Richardson D, Burtenshaw SM, Ibrahim AM, Gladdy RA, Auer R, Beecroft R, Dickson BC, Purgina B, Ambacher K, Nessim C, Swallow CJ. Early and Late Complications of Percutaneous Core Needle Biopsy of Retroperitoneal Tumors at Two Tertiary Sarcoma Centers. Ann Surg Oncol. 2019 Dec;26(13):4692-4698. doi: 10.1245/s10434-019-07656-6. Epub 2019 Aug 1. PMID: 31372868. (This article was used for the SSO: journal-based continuing medical education (CME)/Maintenance of Certification (MOC) program and an editorial was written about this article in Annals of Surgical Oncology by authors from Dana Farber Cancer Center, Harvard - https://link.springer.com/article/10.1245/s10434-019-07723-y)

78. Gilbert RWD, Harvey HM, Nessim C. Malignant melanoma arising from an end ileostomy. BMJ Case Rep. 2019 Aug 1;12(7):e230265. doi: 10.1136/bcr-2019-230265. PMID: 31371335; PMCID: PMC6677946.

79. Raut CP, Callegaro D, Miceli R, Barretta F, Rutkowski P, Blay JY, Lahat G, Strauss DC, Gonzalez R, Ahuja N, Grignani G, Quagliuolo V, Stoeckle E, De Paoli A, Pillarisetty VG, Nessim C, Swallow CJ, Bagaria S, Canter R, Mullen J, Gelderblom HJ, Pennacchioli E, van Coevorden F, Cardona K, Fiore M, Fairweather M, Gronchi A. Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG. Clin Cancer Res. 2019 Apr 15;25(8):2664-2671. doi: 10.1158/1078-0432.CCR-18-2700. Epub 2019 Feb 5. PMID: 30723141.

80. Gawad N, Ibrahim AM, Duffy M, Raiche I, Nessim C. Going Beyond the Numerical Scoresheet: Identifying Maladaptive Narcissistic Traits in Residency Applicants. J Surg Educ. 2019 Jan-Feb;76(1):65-76. doi: 10.1016/j.jsurg.2018.06.024. Epub 2018 Sep 27. PMID: 30270104.

81. Sulaiman A, McGarry S, Lam KM, El-Sahli S, Chambers J, Kaczmarek S, Li L, Addison C, Dimitroulakos J, Arnaout A, Nessim C, Yao Z, Ji G, Song H, Liu S, Xie Y, Gadde S, Li X, Wang L. Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells. Cell Death Dis.2018 Jul 26;9(8):815. doi: 10.1038/s41419-018-0811-7. PMID: 30050079; PMCID: PMC6062597.

82. Hasim MS, Nessim C, Villeneuve PJ, Vanderhyden BC, Dimitroulakos J. Activating Transcription Factor 3 as a Novel Regulator of Chemotherapy Response in Breast Cancer. Transl Oncol. 2018 Aug;11(4):988-998. doi: 10.1016/j.tranon.2018.06.001. Epub 2018 Jun 22. PMID: 29940414; PMCID: PMC6039300.

83. Authors listed in alphabetical order Nessim C et al. Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG). Electronic address: andrea.macneill@bccancer.bc.ca. Management of metastatic retroperitoneal sarcoma: a consensus approach from the Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG). Ann Oncol. 2018 Apr 1;29(4):857-871. doi: 10.1093/annonc/mdy052. PMID: 29432564; PMCID: PMC6354678.

84. Sulaiman A, McGarry S, Li L, Jia D, Ooi S, Addison C, Dimitroulakos J, Arnaout A, Nessim C, Yao Z, Ji G, Song H, Gadde S, Li X, Wang L. Dual inhibition of Wnt and Yes-associated protein signaling retards the growth of triple-negative breast cancer in both mesenchymal and epithelial states. Mol Oncol. 2018 Apr;12(4):423-440. doi: 10.1002/1878-0261.12167. Epub 2018 Feb 21. PMID: 29316250; PMCID: PMC5891054.

85. Crawford AB, Nessim C, Weaver J, van Walraven C. Wait Times for Melanoma Surgery: Is There an Association with Overall Survival? Ann Surg Oncol. 2018 Jan;25(1):265-270. doi: 10.1245/s10434-017-6146-2. Epub 2017 Nov 3. PMID: 29101504.

86. Zhang Y, Seely J, Cordeiro E, Hefler J, Thavorn K, Mahajan M, Domina S, Aro J, Ibrahim AM, Arnaout A, Gravel D, Nessim C. Radioactive Seed Localization Versus Wire-Guided Localization for Nonpalpable Breast Cancer: A Cost and Operating Room Efficiency Analysis. Ann Surg Oncol. 2017 Nov;24(12):3567-3573. doi: 10.1245/s10434-017-6084-z. Epub 2017 Sep 14. PMID: 28913761.

87. Ambacher K, Ibrahim A, Nessim C.  Ensuring a Safe and Qualitative Diagnostic Biopsy for Retroperitoneal Sarcomas. University of Ottawa Journal of Medicine 2017; 7(1): 45-48.

88. Lim RS, Kielar AZ, El-Maraghi RH, Fraser MA, Nessim C, Thipphavong S. Multidisciplinary retroperitoneal and pelvic soft-tissue sarcoma case conferences: the added value that radiologists can provide. Curr Oncol. 2017 Jun;24(3):e171-e175. doi: 10.3747/co.24.3478. Epub 2017 Jun 27. PMID: 28680282; PMCID: PMC5486387.

89. Head L, Nessim C, Usher Boyd K. Innovative practice model to optimize resource utilization and improve access to care for high-risk and BRCA+ patients. Can J Surg. 2017 Feb;60(1):37-44. doi: 10.1503/cjs.001116. PMID: 28234588; PMCID: PMC5373741.

90. Sulaiman A, Sulaiman B, Khouri L, McGarry S, Nessim C, Arnaout A, Li X, Addison C, Dimitroulakos J, Wang L. Both bulk and cancer stem cell subpopulations in triple-negative breast cancer are susceptible to Wnt, HDAC, and ERα coinhibition. FEBS Lett. 2016 Dec;590(24):4606-4616. doi: 10.1002/1873-3468.12496. Epub 2016 Dec 9. PMID: 27859250.

91. Authors listed in alphabetical order Nessim C et al. Trans-Atlantic RPS Working Group. Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group. Ann Surg Oncol. 2016 Oct;23(11):3531-3540. doi: 10.1245/s10434-016-5336-7. Epub 2016 Aug 1. Erratum in: Ann Surg Oncol. 2017 Dec;24(Suppl 3):688-689. doi: 10.1245/s10434-017-5889-0. PMID: 27480354; PMCID: PMC5557018.

92. Tsvetkova E, Marginean C with Nessim C and Verma S. Gastrointestinal Stromal Tumor (GIST) – Paving the Way for Modern Oncology – Epidemiology, Diagnosis, Treatment.  Oncology and Hematology Review 2015; 11(1): 74–86. doi: 10.17925/OHR.2015.11.01.74 

93. Nessim C, Winocour J, Holloway DP, Saskin R, Holloway CM. Wait times for breast cancer surgery: effect of magnetic resonance imaging and preoperative investigations on the diagnostic pathway. J Oncol Pract. 2015 Mar;11(2):e131-8. doi: 10.1200/JOP.2014.002105. Epub 2015 Feb 10. PMID: 25670200.

94. Nessim C, Law C, McConnell Y, Shachar S, McKinnon G, Wright F. How often do level III nodes bear melanoma metastases and does it affect patient outcomes? Ann Surg Oncol. 2013 Jun;20(6):2056-64. doi: 10.1245/s10434-013-2880-2. Epub 2013 Feb 1. PMID: 23370671.

95. Nessim C, Sidéris L, Turcotte S, Vafiadis P, Lapostole AC, Simard S, Koch P, Fortier LP, Dubé P. The effect of fluid overload in the presence of an epidural on the strength of colonic anastomoses. J Surg Res. 2013 Aug;183(2):567-73. doi: 10.1016/j.jss.2013.03.030. Epub 2013 Mar 27. PMID: 23578750.

96. Nessim C, Bensimon CM, Hales B, Laflamme C, Fenech D, Smith A. Surgical site infection prevention: a qualitative analysis of an individualized audit and feedback model. J Am Coll Surg. 2012 Dec;215(6):850-7. doi: 10.1016/j.jamcollsurg.2012.08.007. PMID: 23164141.